KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
May 17, 2022 $0.250 $0.264 $0.240 $0.253 717 985
May 16, 2022 $0.262 $0.264 $0.240 $0.250 559 068
May 13, 2022 $0.259 $0.268 $0.247 $0.260 372 301
May 12, 2022 $0.225 $0.250 $0.219 $0.240 949 510
May 11, 2022 $0.262 $0.278 $0.220 $0.227 994 579
May 10, 2022 $0.300 $0.318 $0.261 $0.263 1 135 959
May 09, 2022 $0.337 $0.341 $0.290 $0.294 1 624 693
May 06, 2022 $0.324 $0.349 $0.318 $0.349 463 243
May 05, 2022 $0.333 $0.341 $0.321 $0.328 473 104
May 04, 2022 $0.320 $0.334 $0.311 $0.331 377 807
May 03, 2022 $0.317 $0.342 $0.317 $0.327 565 506
May 02, 2022 $0.322 $0.331 $0.308 $0.317 668 526
Apr 29, 2022 $0.321 $0.330 $0.308 $0.308 445 182
Apr 28, 2022 $0.310 $0.331 $0.308 $0.331 527 173
Apr 27, 2022 $0.320 $0.330 $0.310 $0.317 736 159
Apr 26, 2022 $0.331 $0.337 $0.317 $0.322 472 605
Apr 25, 2022 $0.318 $0.333 $0.317 $0.331 356 957
Apr 22, 2022 $0.330 $0.332 $0.313 $0.315 175 347
Apr 21, 2022 $0.320 $0.333 $0.310 $0.326 567 100
Apr 20, 2022 $0.330 $0.334 $0.318 $0.328 459 900
Apr 19, 2022 $0.320 $0.337 $0.312 $0.330 486 600
Apr 18, 2022 $0.345 $0.349 $0.311 $0.312 991 200
Apr 14, 2022 $0.346 $0.374 $0.340 $0.345 1 194 580
Apr 13, 2022 $0.333 $0.350 $0.311 $0.340 1 625 608
Apr 12, 2022 $0.300 $0.365 $0.300 $0.350 1 921 018
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT